Conversation 159: This stock popped 40% in a day. Is it just the beginning?

This health technology product is so far ahead of existing techniques that it will be able to charge a premium on the current $80 to $100 being spent by customers for each test, according to the Executive Chair of the company.

And with 2.3m test cycles conducted in their target market annually, hitting their predicted initial market sales target of 24% would create a healthy revenue stream right out of the box.

Find out more about this company and why the Executive Chair is so confident about sales starting in the fourth quarter of this year.